ApprovalTrail

Approval · Notice of Compliance 27103 · 2021

PLIAGLIS: Notice of Compliance 27103

Issued November 25, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
27103
Date
November 25, 2021
Company
Sciences de la Peau CRESCITA Inc.Laval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Administrative: Manufacturer Name Change

Products in this notice

BrandDINStatus today
PLIAGLIS02398028Marketed

Medicinal ingredients